Torres Jesus, Avalos Nathaniel, Echols Lamarr, Mongelluzzo Jillian, Rodriguez Robert M
Department of Emergency Medicine, University of California, San Francisco, CA, United States.
Department of Emergency Medicine, University of California, San Francisco, CA, United States.
Am J Emerg Med. 2017 Aug;35(8):1159-1161. doi: 10.1016/j.ajem.2017.05.039. Epub 2017 May 26.
Current guidelines recommend blood cultures in skin and soft-tissue infection (SSTI) patients only with signs of systemic toxicity and wound cultures for severe purulent infections. Our objectives were to determine: 1) blood and wound culture yields in patients admitted with SSTIs; 2) whether injection drug users (IDUs) and febrile patients had higher blood culture yields; and 3) whether blood and wound cultures grew organisms sensitive to typical SSTI empiric antibiotics.
We prospectively enrolled adult patients admitted from the ED with SSTIs at an urban hospital. We recorded patient characteristics, including IDU, comorbidities and temperatures, and followed admitted patients throughout their hospital course.
Of 734 SSTI patients enrolled, 246 (33.5%) were admitted. Of 86 (35.0%) patients who had blood cultures, six had positive cultures (yield=7.0%; 95% confidence intervals [CIs] 3.2-14.4); 4 were methicillin sensitive Staphylococcus aureus (MSSA) and 2 were methicillin resistant (MRSA). Of 29 febrile patients, 1 had a positive culture (yield=3.5%; 95% CI 0.6-17.2). Of 101 admitted IDU patients, 46 (46%) received blood cultures, and 4 had positive cultures (yield=8.7%; 95% CI 3.4-20.3). Of 89 patients with purulent wounds, 44 (49.4%) patients had ED wound cultures. Thirteen had positive cultures (yield=29.6%; 95% CI 18.2-44.2%). Most were MRSA, MSSA, and group A Streptococcus species - all sensitive to Vancomycin.
Febrile and IDU patients had low yields of blood cultures similar to yields in non-IDU and afebrile patients. All blood and wound culture species were adequately covered by currently recommended empiric antibiotic regimens.
当前指南建议,仅对有全身中毒症状的皮肤和软组织感染(SSTI)患者进行血培养,对严重化脓性感染患者进行伤口培养。我们的目标是确定:1)因SSTI入院患者的血培养和伤口培养阳性率;2)注射吸毒者(IDU)和发热患者的血培养阳性率是否更高;3)血培养和伤口培养分离出的微生物是否对典型SSTI经验性抗生素敏感。
我们前瞻性纳入了一家城市医院急诊科收治的成年SSTI患者。我们记录了患者特征,包括是否为IDU、合并症和体温,并在患者整个住院期间进行随访。
纳入的734例SSTI患者中,246例(33.5%)入院。86例(35.0%)进行血培养的患者中,6例培养结果为阳性(阳性率=7.0%;95%置信区间[CI] 3.2 - 14.4);4例为甲氧西林敏感金黄色葡萄球菌(MSSA),2例为甲氧西林耐药(MRSA)。29例发热患者中,1例培养结果为阳性(阳性率=3.5%;95% CI 0.6 - 17.2)。101例入院IDU患者中,46例(46%)接受了血培养,4例培养结果为阳性(阳性率=8.7%;95% CI 3.4 - 20.3)。89例有化脓性伤口的患者中,44例(49.4%)在急诊科进行了伤口培养。13例培养结果为阳性(阳性率=29.6%;95% CI 18.2 - 44.2%)。大多数为MRSA、MSSA和A组链球菌——均对万古霉素敏感。
发热患者和IDU患者的血培养阳性率较低,与非IDU和非发热患者的阳性率相似。目前推荐的经验性抗生素方案能充分覆盖所有血培养和伤口培养分离出的菌种。